DKMS Registry and DKMS UK achieve WMDA qualification status
The DKMS Registry and DKMS UK are officially "WMDA qualified". This qualification certifies that both organizations are committed to and comply with internationally accepted benchmark standards for unrelated hematopoietic stem cell donation as defined by the WMDA. It is the required first step toward WMDA accreditation.
Also, as the DKMS Registry operates as the international registry for DKMS Chile and for DKMS BMST India, DKMS donors from India and Chile are from now on also listed with the addition "WMDA qualified" in the worldwide search of WMDA, the global stem cell donor pool.
“At DKMS UK we’re delighted with our recent WMDA qualification success. We’re trying to create a culture of continuous improvement and meeting the WMDA benchmark standards is a key building block in the quality assurance and improvement process,” says Jonathan Pearce, Chief Executive Officer of DKMS UK.
The mission of the WMDA is to promote global collaboration and sharing of best practices for the benefit of stem cell donors and transplant patients. To qualify, evidence must be provided that operations are conducted in accordance with the WMDA's so-called "benchmark standards."
“This is an important milestone for the DKMS Registry and DKMS UK and encourages us to take the next step towards WMDA accreditation”, says Dr. Julia Pingel, Chief Operating Officer at the DKMS Registry.